Sepsis is a significant global public health challenge, resulting in millions of human deaths annually. Transient receptor potential melastatin 8 (TRPM8), a non-selective
ion channel, is the primary cold sensor in humans; however, its effects on
endotoxin-induced
inflammation remain unclear. We previously reported that TRPM8 knockout mice exhibited more severe physiological and behavioral
endotoxemia responses upon a high-dose injection with
lipopolysaccharide (LPS). In the present study, we investigated whether
icilin, a TRPM8 agonist, was a target for the suppression of sickness responses using a mouse model of LPS-induced
sepsis. A peripheral high-dose injection of LPS at 5 mg/kg showed a maximal body temperature decrease of 5.1 °C in mice subcutaneously pretreated with vehicle and 1.5 °C in
icilin-pretreated animals. The decline in locomotor activity was attenuated in
icilin-pretreated mice and its recovery was faster; however, the high-dose LPS injection rapidly decreased locomotor activity regardless of the
icilin pretreatment. Furthermore, the
icilin pretreatment attenuated LPS-induced decreases in
body weight and food and water intakes and accelerated recovery from these sickness responses. Therefore, the present results demonstrated that the
icilin pretreatment alleviated LPS-induced sickness responses or decreases in body temperature, locomotor activity,
body weight loss, and food and water intakes, suggesting its potential as a therapeutic target for
sepsis.